ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

Go back to ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
Immucell Corp (NASDAQ: ICCC) Delayed: 10.13 --0 (-0%)
Previous Close $10.13    52 Week High $8.29 
Open $10.13    52 Week Low $4.99 
Day High $10.13    P/E 126.63 
Day Low $10.13    EPS $0.08 
Volume 957